MedPath

Blind Fascia Iliaca Compartment Block Compared to Ultrasound-guided Femoral Nerve Block in Patients With Hip Fractures

Conditions
Hip Fractures
Interventions
Procedure: Fascia Iliaca Compartment Block
Procedure: Femoral Nerve Block
Registration Number
NCT05365555
Lead Sponsor
University Hospital, Linkoeping
Brief Summary

The goal of this study is to compare the analgesic effect of a blind fascia iliaca compartment block to an ultrasound-guided femoral nerve block in patients that present to the emergency department with hip fractures.

Detailed Description

Hip fractures often present to the emergency department and elderly, already fragile, patients are overrepresented. The pain associated with a hip fracture can be severe and have deleterious effects on the patient. Many studies, and a Cochrane review, have shown that a peripheral nerve block provides good pain relief and has many benefits compared to traditional pain relief, such as intravenous morphine. There is less consensus regarding which kind of nerve block, and which technique, is best to use. Many studies compared different kinds of nerve blocks to traditional methods, or more recently compared different kinds of ultrasound-guided techniques to each other.

This study proposes to compare the widely used technique of a blind fascia iliaca compartment block (FICB) to an ultrasound-guided femoral nerve block (FNB) that is currently being rolled out locally as an alternative. During the implementation period of this new clinical routine, it will be possible to compare the efficacy of FICB and FNB in reducing participant-reported pain.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Adult emergency department patient over 18 years of age with a radiologically verified fracture classified as hip fracture that are eligible for a peripheral nerve block according to local guidelines
Exclusion Criteria
  • Multi-system trauma
  • Isolated pelvic or diaphyseal femur fracture
  • Patients unable to communicate regardless of reason
  • Patients with contraindications to receiving a peripheral nerve block with an amide local anaesthetic according to local guidelines

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Fascia Iliaca Compartment Block (FICB)Fascia Iliaca Compartment BlockParticipants with a radiologically verified hip fracture receiving a FICB using a blind technique guided by anatomical landmarks.
Fascia Iliaca Compartment Block (FICB)RopivacaineParticipants with a radiologically verified hip fracture receiving a FICB using a blind technique guided by anatomical landmarks.
Femoral Nerve Block (FNB)Femoral Nerve BlockParticipants with a radiologically verified hip fracture receiving a FNB using ultrasound guidance for direct nerve visualisation.
Femoral Nerve Block (FNB)RopivacaineParticipants with a radiologically verified hip fracture receiving a FNB using ultrasound guidance for direct nerve visualisation.
Primary Outcome Measures
NameTimeMethod
Mean Change from Baseline in Pain Scores on the Numeric Rating Scale (0 to 10, where 10 is Maximum Pain) at 30 minutes after Administration of Block, at Rest and During Active Hip FlexionMeasured 30 minutes after administered nerve block.

Change in reported pain score should be at least one whole unit on the numeric rating scale.

Secondary Outcome Measures
NameTimeMethod
Rate of ComplicationsThrough study completion, an average of 1 year

Comparing the rate of any reported complication between cohorts

Ratio of Failed BlocksThrough study completion, an average of 1 year

Defined by a failure to reduce reported pain 30 minutes after administered block by at least one whole unit on the numeric rating scale

Trial Locations

Locations (1)

Akutmottagningen US Östergötland

🇸🇪

Linköping, Östergötland, Sweden

Akutmottagningen US Östergötland
🇸🇪Linköping, Östergötland, Sweden
Daniel Wilhelms, PhD
Contact
+46101033000
daniel.wilhelms@regionostergotland.se
Erika Hörlin, Msc
Contact
+46101033041
erika.horlin@regionostergotland.se

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.